Brief: Medicure Announces AGGRASTAT Shows Promise In Treating Thrombotic Complications Due To COVID-19
24/08/2020 19:03
Aug 24 (Reuters) - Medicure Inc MPH.V :
* MEDICURE ANNOUNCES AGGRASTAT® SHOWS PROMISE IN TREATING
THROMBOTIC COMPLICATIONS DUE TO COVID-19 IN EARLY CLINICAL
REPORTS
* MEDICURE - EARLY INVESTIGATOR SPONSORED CLINICAL REPORTS
FOR
AGGRASTAT SHOW PROMISE FOR PREVENTING, TREATING THROMBOTIC
COMPLICATIONS DUE TO COVID-19
Source text for Eikon: ID:nPn5r8ypHa
Further company coverage: MPH.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicure
See all newsBrief: Medicure Announces Resignation Of Board Member And Grant Of Stock Options
Brief: Medicure Posts Qtrly Earnings Per Share $0.11
Brief: Medicure Reports Financial Results For Quarter Ended June 30, 2022
Brief: Medicure Announces Resignation Of CFO And Succession Plan
Brief: Algernon Pharmaceuticals Appoints James Kinley As CFO Effective From December 1, 2021